Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia
NCT ID: NCT01544608
Last Updated: 2013-06-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1076 participants
OBSERVATIONAL
2012-07-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients
NCT00921804
An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia
NCT02640911
Pharmacologic Treatment of Acute Episode of Schizophrenia: a Real World Study
NCT03289026
A Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital Setting
NCT01926912
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
NCT01432444
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects who are hospitalized due to acute psychotic episode.
All subjects who are hospitalized due to acute psychotic episode. The subjects should be managed according to normal clinical practice until discharge time.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is hospitalised due to an acute psychotic episode.
* Ability of the subject to understand and comply with the requirements of the study, as judged by the investigator.
Exclusion Criteria
* Previous enrolment in the present NIS (in case of recurrence occurred during the enrolment period).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Talaat Matar, CONSULTANT PSYCHIATRIST
Role: STUDY_CHAIR
Obaid Alla Hospital,Ras Al Khaima,UAE
Tarek Darwish, CONSULTANT PSYCHIATRIST
Role: STUDY_CHAIR
Sheikh Khalifa Medical City(SKMC), Abudhabi,UAE
Sohail Khan, CONSULTANT PSYCHIATRIST
Role: STUDY_CHAIR
Jeddah Psychiatric hospital,Jeddah, Saudi Arabia
Tarek Okasha, PROFESSOR
Role: STUDY_CHAIR
Ain Shams University, Cairo, Egypt
Mohamed Nasr, PROFESSOR
Role: STUDY_CHAIR
Cairo University, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Cairo, , Egypt
Research Site
Dammam, , Saudi Arabia
Research Site
Jeddah, , Saudi Arabia
Research Site
Riyadh, , Saudi Arabia
Research Site
Abu Dhabi, , United Arab Emirates
Research Site
Dubai, , United Arab Emirates
Research Site
Ras al-Khaimah, , United Arab Emirates
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-NME-XXX-2011/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.